Асосий контентга ўтиш

Patrick Flamen

1 та иш

Active Medicine (United Kingdom)

  1. Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma

    Tarik Belhocine, Gérald Pierard, J Frühling +6

    Мақола20062 иқтибос
    ABI